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Given health budget constraints, priority setting for new programs is unavoidable, whether done explicitly 
or implicitly. Policy makers may use cost-
effectiveness analysis (CEA) to help inform 
resource allocation decisions. It is usual 
practice in CEA to focus on ‘efficiency’ with 
the aim of maximizing health benefits for the 
lowest cost or minimising cost for a specified 
outcome. Efficiency is important, but only 
one of several policy objectives. Government 
statements about health usually include 
important notions of equity – reducing 
disadvantage, access to health services, 
and/or affordability.1 Further, when the 
community in developed countries is asked 
what they want from their health care system, 
a ‘fair’ distribution of health gains is often 
seen as an important objective.2-10
Cost-effectiveness analysis (CEA) compares 
the relative costs and outcomes of a policy 
or program. The results of CEAs are usually 
summarised as incremental cost-effectiveness 
ratios (ICERs) that represent the additional 
costs and benefits of an intervention 
measured against a comparator. To present 
a helpful metric across different types of 
interventions, results are often presented as 
the ‘net cost per quality adjusted life year’ 
(QALY). To help determine value-for-money, 
an ICER threshold is often applied (e.g. 
<AUD$50,000 per QALY), below which an 
intervention is presumed ‘efficient’. When 
a policy is being analysed for its cost-
effectiveness, information regarding the 
equity in the distribution of health outcomes 
is rarely provided.11,12
Most CEAs either ignore health inequality 
impacts or limit themselves to a description 
of their nature without any quantification 
or consideration of intervention design 
changes to address inequality. While this 
applies across clinical medicine and public 
health, approaches to incorporate equity 
are likely to differ between these settings. 
The individualised nature of health care, for 
instance, is different to the population focus 
of public health, where confronting inequality 
may require discrimination between groups 
of relatively healthy people, for example, 
in the number and quality of preventative 
programs. In clinical care settings, this would 
be problematic. Equity is important in both 
settings, but here we focus on public health. 
In any country, differences in health status 
can be observed across the population. 
Explicit health equity assessment is not 
always necessary. However, it can become 
important when, for example, a public health 
intervention is not cost-effective, and the 
question then arises of how much it reduces 
health inequality to not exclude this potential 
source of value.11
The health equity impact plane in Figure 1  
illustrates the trade-offs between cost 
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Abstract
Objectives: To assess current approaches to inclusion of equity in economic analysis of public 
health interventions and to recommend best approaches and future directions.
Methods: We conducted a systematic review of studies that have used socioeconomic position 
(SEP) in cost-effectiveness analyses. Studies were identified using MedLine, EconLit and HEED 
and were evaluated based on their SEP specific inputs and methods of quantification of the 
health and financial inequalities.
Results: Twenty-nine relevant studies were identified. The majority of studies comparing 
two or more interventions left interpretation of the size of the health and financial inequality 
differences to the reader. Newer approaches include: i) use of health inequality measures 
to quantify health inequalities; ii) inclusion of financial impacts, such as out-of-pocket 
expenditures; and iii) use of equity weights. The challenge with these approaches is presenting 
results that policy makers can easily interpret.
Conclusions: Using CEA techniques to generate new information about the health equity 
implications of alternative policy options has not been widely used, but should be considered 
to inform future decision making.
Implications for public health: Inclusion of equity in economic analysis would facilitate a more 
nuanced comparison of interventions in relation to efficiency, equity and financial impact.
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effectiveness and an alternative health equity 
objective.11 Cost-effectiveness of the health 
program is shown on the vertical axis and 
the health equity impact on the horizontal 
axis. The latter represents the net impact 
after allowing for program opportunity costs 
and benefits. A policy that falls in Quadrant I 
improves both total health and equity (“win-
win”); in Quadrant III, the policy harms both 
(“lose-lose”). In these two cases, the impacts 
on health maximisation and health equity are 
in the same direction, so there are no trade-
offs. In Quadrant II, the policy has a positive 
impact total health but a negative impact on 
equity (“win-lose”), and in Quadrant IV, the 
policy has a negative impact on total health 
but a positive impact on equity (“lose-win”).
The main method of quantifying the health 
impact among different population groups 
within a CEA is to conduct subgroup CEAs, 
which entails a separate CEA for each 
socioeconomic position (SEP) subgroup to 
determine the costs and health gains in each 
group. Where interventions only require a 
whole of population CEA and are not set 
up for subgroup CEAs (e.g. population-
wide strategies that are not targeted at 
certain groups), the subgroup health gains 
can be modelled. Despite measurement 
challenges, estimating the health gains of 
subgroups in population health strategies 
has the potential to allow policy makers 
to assess interventions not only for their 
cost-effectiveness, but also for their potential 
impact on health inequality. The objectives 
of this type of analysis are transparency and 
policy relevance, particularly where there is 
potential to increase inequalities in health 
status in already disadvantaged groups. 
If interventions result in financial costs (or 
expenditure avoided) to individuals, it is 
also important to include this as part of the 
equity analysis. When a fiscal policy is being 
analysed it is necessary to consider whether 
it is regressive (taking a proportionally higher 
amount from those on lower incomes), or 
progressive (taking a proportionally higher 
amount from those on higher incomes). If 
the analysis shows that a higher proportion 
of expenditure comes from disadvantaged 
groups, it can then be determined whether 
and how the financial impact could be 
reduced.
There is an important distinction to be made 
between ‘health inequality’ and ‘health 
inequity’. Health inequities are differences 
in health status between population groups 
that are the result of economic and social 
conditions.14,15 They are considered avoidable 
and unfair. Inequity is a normative term linked 
to notions of social justice. Health inequality 
on the other hand, is a descriptive term that 
reports the distribution of a chosen metric. 
When conducting a subgroup CEA to 
measure the health equity impact, the 
choice of the relevant population subgroup 
depends on which characteristic – SEP, 
ethnicity, geographical location, or gender 
– is important in the decision context. In 
the developed world, the single strongest 
predictor of an individual’s health is his/her 
position on the socioeconomic spectrum.16 
SEP can be measured by income, education, 
place of residence or occupation. On average, 
those at the lower end of the spectrum, 
irrespective of how SEP is measured, 
are more likely to suffer from diseases, 
have higher mortality rates and lower life 
expectancies.16-20 This social gradient of 
health is also important for many racial and 
ethnic health differences because SEP can 
differ substantially by race and ethnicity.21-24 
In an analysis of government policies in 
thirteen countries, Crombie found that 
inequalities in health were most commonly 
presented as the difference in health status 
between SEP and that all countries had 
set an overarching goal to reduce such 
inequalities.25 Our study is focused on 
socioeconomic health inequalities of public 
health interventions. 
In response to growing policy concerns 
about health equity, economic evaluation 
techniques are being enhanced to provide 
useful evidence about health equity 
impacts and trade-offs. However, there 
has been no systematic evaluation of 
the advantages and disadvantages of 
the different published works that have 
incorporated equity for SEP into CEA. The 
aim of the present work was to review the 
studies that used SEP subgroup economic 
analyses to investigate socioeconomic 
health inequalities in the context of public 
health interventions. Subgroup CEA is a 
basis on which other methods of equity, 
such as measures of health inequality, equity 
weighting and opportunity cost analysis 
could be incorporated.13 We aimed to assess 
the application, challenges and suitability 
of methods utilised in different contexts. 
Recommendations for future studies to 
improve the information available to policy 
makers are discussed.
Methods
Search strategy
Studies were identified using the following 
academic databases: Medline Complete, 
Health Economic Evaluations Database 
(HEED) and EconLit. All original research 
articles published in English were open for 
inclusion, with no restrictions on years of 
publication. Additional snowballing searches 
of reference lists were undertaken. 
The specific search terms were: (“cost-
effectiveness” OR “cost-utility” OR “cost-
benefit” OR “cost-consequence” OR “economic 
evaluation” OR “economic analysis”) AND 
Figure 1: Health Equity Impact Plane.11
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(socioeconomic* OR “social class” OR “social 
hierarchy” OR “social inequality” OR depriv* 
OR disadvantage* OR income OR educational 
OR occupation OR residence) NOT “low-
income countr*”.
To estimate a percentage of the total number 
of economic evaluations of public health 
programs or policies that have used SEP 
subgroup analysis, the Econlit database 
was used. Econlit classifies studies under 
the subheading “Health government policy 
regulation; public health”. The specific search 
terms used were: (“cost-effectiveness” OR 
“cost-utility” OR “cost-benefit”). 
Study selection and inclusion criteria
Included studies were assessed for their 
relevance by one reviewer (AL). Studies 
that assessed public health interventions 
using economic evaluation techniques 
that compare alternative courses of action 
in terms of both costs (resource use) and 
consequences (outcomes, effects) and 
stratified SEP group/s were included. Cost-
utility analysis (CUA) is a form of CEA whereby 
the health outcomes are measured in terms 
of both the length of life and the quality of 
that life (usually QALYs). Cost-effectiveness 
analysis measures outcomes in physical units 
meaningful to clinicians and patients, such 
as a ‘cost per death averted’. Our aim was to 
include interventions that address a whole 
population across a socioeconomic gradient, 
as well as interventions targeted only at lower 
SEP groups. Accordingly, included studies 
were those that were aimed at a whole 
population, a community, or were targeted 
at specific individuals and groups of people 
within a country, community or organisation. 
Studies were excluded by one reviewer (AL) if 
they: 1) were not public health interventions 
or policies; 2) examined groups that were 
not SEP-based, such as ethnic group or age 
differences; or 3) analysed a low-income 
country as one population. 
Study appraisal 
Data on the following variables were 
extracted: country, aims, perspective, 
study type, intervention and comparator, 
population subgroups, SEP specific modelling 
inputs, health outcomes and financial 
outcomes.
The studies were appraised based on: i) the 
number and type of SEP specific inputs in the 
model; ii) level of complexity of quantification 
of the health inequality; iii) methods of 
incorporating the equity analysis into the 
CEA; and iv) inclusion of financial costs. 
Results
The literature search yielded a total of 426 
papers. The reading of titles and abstracts 
indicated that 44 of the articles were 
potentially eligible. After examination of the 
full text of these articles, the final number 
of studies included was 31. Reasons for 
excluding full-text articles are shown in Figure 
2. Of the 576 economics evaluations of public 
health interventions identified in Econlit 
database, 5% were studies that used SEP 
subgroup CEA.
Overview of included studies 
Date of publication ranged from 2010 to 
2015. Of the 31 included studies, 15 examined 
two or more SEP subgroups and 16 studies 
analysed a low SEP group only. A summary 
of each of these studies including the SEP 
specific inputs and outcomes and policy 
relevance of each study is provided in the 
supplementary files. 
Studies examining two or more SEP 
subgroups
Intervention types 
The main type of intervention analysed 
(n=8) was vaccination programs for the 
prevention of a range of conditions, 
including rotavirus,26,27 pneumonia,28 
human papillomavirus,29,30 measles31 and 
tuberculosis.32 Three studies looked at fiscal 
policies, including an increase in tobacco 
taxes33,34 and a subsidy and tax decrease 
for fresh fruit and vegetables.35 There were 
also studies that examined bowel screening 
programs,36 a ban on trans fats,37 promotion 
of physical activity in adults,38 promotion of 
physical activity and nutrition in children39 
and coronary heart disease management.40
Seven studies were CUAs30,34,36-40 and eight 
studies were CEAs.26-29,31-33,35 Seven studies 
compared two or more interventions 
to current practice,28,30,31,34-37 while the 
remainder compared a single intervention 
to current practice. Studies originated from 
a range of low, middle and high-income 
countries.41 There were three interventions 
each from the United Kingdom,36-38 
India26,27,32 and Ethiopia,26,28,31 two from 
China29,33 and New Zealand,30,39 and one 
each from the Netherlands,34 Australia40 and 
France.35
Measures of socioeconomic position
The most commonly used measure of SEP 
was household income or wealth quintiles, 
utilised in eight of the 15 studies.26-29,31-33,35 
Five studies used area level deprivation 
or disadvantage that took into account 
multiple factors such as employment, income, 
education and housing.30,36,38-40 One study 
used education level as the indicator of SEP.34 
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Assessment of the studies 
Aims of the studies: For 14 of the 15 
studies,26-38,40 the main aims included the 
evaluation of the health outcomes across SEP 
groups. The remaining study did not explicitly 
mention an aim to analyse the health benefits 
by SEP groups.39 
SEP specific inputs in modelling: A 
comprehensive SEP specific model, using 
rates of effectiveness, disease specific 
incidence, morbidity and mortality rates, 
specific to the subgroups was found in 10 
studies.26-28,30,31,34,36-38,40 Two studies used 
a simplistic model where the intervention 
effect size was the only SEP-specific input in 
the model.35,39
Studies examining one SEP subgroup
Intervention types 
Of the 14 studies examining a targeted 
SEP group, six were CUAs,42-47 and eight 
were CEAs.48-55 The majority of the studies 
originated from the USA (n=9);42,45-47,49,50,52,54,55 
three came from the UK;43,44,53 and one each 
from Australia51 and Iran.48
Measures of socioeconomic position
Eight studies used low income as a measure 
of SEP42,45,46,48,50,52,55,56 and six studies used an 
area-based level of disadvantage.43,44,49,51,53,54
Assessment of the studies 
Aims of the studies: The aims of all the studies 
analysing one SEP group were to examine 
the cost-effectiveness of the intervention 
targeting a low SEP group. 
SEP specific inputs in modelling: For the 
modeling of morbidity and mortality in the 
CUAs, one study used SEP specific mortality 
inputs,44 while the other four studies used 
general population inputs.42,45-47 In the 
CEA studies, all studies used SEP-specific 
effectiveness/efficacy rates either from the 
trial on which the study was based or from 
published sources.
Interpretation and quantification of 
the health inequality
In 12 of the 14 studies that aimed to evaluate 
the differences in health benefit between 
SEP groups, the health outcomes of each SEP 
group were presented, such as QALY gain per 
person.30,34,38,40 While it was left to the reader 
to interpret the size of the differences, the 
studies did state which SEP group had the 
highest or lowest gains. Two of the studies 
confined their attention to the highest and 
lowest groups, and did not include the health 
gains of the middle groups in their results.30,38 
Three studies presented the results as 
the total QALYs in each SEP group. Two of 
the studies36,37 used population quintiles. 
However, one study used different-sized 
groups and stated that the highest health 
gains occurred in the middle SEP groups.34 
This was true for the overall number of QALYs, 
however these absolute differences will vary 
depending on the size of the group. In this 
study, calculation of the ratio of QALYs gained 
per smoker would have changed the result 
to the highest gains being in the highest SEP 
group. 
Health equity impact plane
One study used a diagram of a health equity 
impact plane to summarise the net costs 
and the reduction in absolute inequality of 
coronary heart disease mortality for each 
policy option.37
Health inequality measures
Measures of health inequality are single 
numbers that quantify the size of SEP 
inequalities in health and can be classified as 
simple or complex.57 Simple measures make 
pairwise comparisons of health between 
two subgroups, such as a lower and a higher 
SEP group. Complex health inequality 
measurements produce a single number that 
considers all SEP groups separately and assess 
how the rate of health gains vary across the 
gradient of SEP.57 Measures of inequality can 
be relative or absolute. 
Simple health inequality measures were 
included in one study35 – a health disparities 
index – defined as the variation in the odds 
ratio for the first vs. other income deciles 
for each policy. The opportunity to quantify 
and compare the inequality impact of 
interventions was missed by four28,30,31,34 of 
the seven studies that analysed two or more 
interventions.28,30,31,34-37 
Complex health inequality measures were 
used by two studies, both of which used a 
slope index of inequality.36,37 The study by 
Asaria et al. provided a new methodological 
framework for undertaking distributional 
cost-effectiveness analysis (DCEA) to 
combine the objectives of maximising 
health and minimising unfair variation in 
health when evaluating population health 
interventions.36 Their methods included 
complex health inequality indices alongside 
CUA. They analysed two redesign options for 
an existing screening program: i) a targeted 
reminder for disadvantaged groups; and 
ii) a universal reminder. A battery of both 
relative and absolute measures of inequality 
for each intervention were presented. Five 
decimal places are shown to differentiate the 
numbers, and the differences in the size of 
the inequality measures between strategies 
appear very small. The importance of these 
small differences is not explained. 
Equity Weights
There is an implicit equity approach in CEA 
that assigns an equal value to each unit of 
health gain regardless of the intervention 
or its recipients. Equity weights are a way 
of formally incorporating alternative equity 
positions into economic evaluation.58 The 
weights are numbers that represent the 
relative importance of equity for SEP.
Two studies used a form of equity weighting 
when quantifying the health inequality 
impact. Asaria et al.36 report the Kolm and 
Atkinson indices to measure inequality 
(see Supplementary Table 1), allowing for 
different levels of aversion to inequality, 
a measure of the overall health gains that 
society is willing to give up in order to achieve 
a more equal distribution of health. They 
present a low, medium and high value of 
aversion to inequality. All of the inequality 
measures, calculated across a range of 
inequality aversion levels, show that no 
screening was the least unequal and the 
universal reminder as the most unequal 
of the strategies. Banham et al.40 present a 
method for weighting resource allocation, 
in situations where distribution of the same 
level of resources per capita to each SEP 
group would increase the inequalities due 
to different intervention effect sizes. If the 
policy objective is to reduce inequalities, 
the approach suggests weighting resource 
allocation, using the highest quintile as a 
benchmark and based on the difference 
between highest and lowest quintile specific 
intervention effects. For example, the 
weight for Quintile 1 would be 1.65, based 
on the difference between the effect sizes 
of Quintiles 5 and 1 of 18.8% and 11.4% 
respectively, divided by 11.4%.
Financial impacts 
Financial impacts are measured in terms 
of market place transactions, consisting of 
out-of-pocket expenses avoided or incurred 
because of the intervention.
The novel framework of extended cost-
effectiveness analysis (ECEA) emerged 
Lal et al. Article
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from this review and includes two financial 
aspects of inequality across wealth strata 
of a population: i) the out-of-pocket (OOP) 
expenditure avoided; and ii) the level of 
financial risk protection (FRP) provided by the 
value of insurance afforded. ECEA was used 
by six studies from low and middle income 
countries.41,26,28,29,31-33 Four studies have used 
the ECEA framework fully with the health 
benefits measured in ‘deaths averted’ across 
income quintiles and financial impacts of out-
of-pocket treatment expenditures avoided 
and the FRP afforded.26,28,32,33 Two studies 
omitted the FRP and reported a percentage 
change in expected income.29,31 For example, 
Verguet et al. provide an alternate scenario 
to Universal Public Financing (UPF) of 
tuberculosis treatment in India, by reducing 
the cost of borrowing for the poor. Instead 
of health gains and the insurance value of 
UPF accruing primarily to the poor, lowering 
costs of borrowing for the poor could 
potentially achieve some of the health gains 
of UPF, lower costs to the public sector and 
improvements in the net income position of 
the top two income quintiles, but at the cost 
of leaving the poor more deeply in debt.32
Of the 29 studies, three studies examined 
fiscal policies;33-35 however, only one reported 
the financial impact. Comprehensive 
financial impacts were presented showing 
that increased tobacco taxation can be a 
pro-poor policy instrument in China, by 
substantially decreasing tobacco expenditure 
in the poorest quintile and by decreasing 
expenditure on tobacco-related diseases and 
providing financial risk protection mainly 
concentrated in the poorest households.33
Analysis of opportunity cost
The opportunity cost could be the QALYs 
forgone when there is an equity-efficiency 
trade-off, such as between improving overall 
population health and the equity goal of 
reducing the health inequality between 
SEP groups. The latter may require diversion 
of additional resources to these harder to 
reach groups. The net equity impact of an 
intervention includes the health benefits 
forgone as well as the health benefits 
gained. The forgone health gains or health 
opportunity costs that could have resulted 
from implementing the next best alternative 
program may be unequally distributed 
among SEP groups.
The opportunity costs were analysed by one 
study.36 The authors’ method of estimating 
the distribution of opportunity cost was 
to assume that the additional costs come 
from a fixed health budget and the health 
opportunity cost of the disinvestment of 
these funds within the National Health 
Service was one QALY per £20,000. The base 
case assumed that the opportunity costs 
were distributed equally across all population 
subgroups. Subsequently, two sensitivity 
analyses were performed assuming the 
costs were borne entirely by the healthiest 
subgroup and secondly by the unhealthiest 
subgroup. The results are presented as social 
welfare indices with five decimal places to 
distinguish the differences in magnitude. 
These differences are not easily interpreted 
and an explanation of the implications of the 
small differences in magnitude would have 
been useful. 
Discussion
The aim of this paper was to examine 
studies that have used SEP subgroup CEA 
analysis and to assess how they identify 
and measure health inequalities in public 
health interventions. The key methods from 
the studies included: i) the use of health 
inequality measures to show the inequality 
differences when two or more interventions 
are being compared; ii) the analysis of 
financial impacts such as out-of-pocket 
treatment expenditures avoided; iii) the 
use of SEP specific inputs for mortality and 
morbidity, especially in the studies that 
analysed effects across different SEP groups; 
and iv) the use of equity weights. 
We found the main weakness to be 
that in most studies where two or more 
interventions were being compared, there 
was a reliance on disaggregated data and the 
interpretation of the size differences of the 
inequality was left to the reader. Also, some 
studies did not include financial impacts 
when they were a potentially important 
aspect of the intervention and some studies 
confined their attention to the highest and 
lowest SEP groups and potentially omitted 
important results from the middle groups. 
The study by Asaria et al.36 broke new 
ground in providing a DCEA framework by 
presenting complex inequality measures, 
including aversion to inequality values and 
equity weighting analysis. The framework 
demonstrated how alternative social 
judgments influence the assessment of which 
strategy is best. Social welfare analysis can 
be a useful way of ranking interventions to 
decide which one best minimises health 
inequalities and/or maximises health, taking 
into account people’s aversion to inequality. 
The study demonstrated the use of equity 
weights to explore the implications of 
alternative value judgments. One of the 
features of Asaria et al.’s methodology36 is the 
transparency about value judgments and the 
use of sensitivity analyses to reflect alternative 
value judgments. Lack of consensus on an 
equity weight algorithm has raised doubts 
about equity weight analysis.11 However, this 
type of analysis is recommended to be used 
as an aid to analyse the implications of using 
alternative value judgments via sensitivity 
analysis and not necessarily as an algorithm 
for making decisions.11
ECEA has also emerged as a framework for 
incorporating health and financial inequality 
impacts into economic evaluation in low 
and middle-income countries. Examining 
the financial impacts across SEP groups is 
an important advance in analysing equity in 
CEA. Although the framework has only been 
used in low and middle-income countries, 
aspects of ECEA would be useful in analyses 
originating from high income countries also; 
the analysis of out-of-pocket costs incurred 
and averted across SEP groups is highly 
relevant in any country when the impacts 
differ. 
When assessing the equity impact of an 
intervention, the distribution of both health 
gains and opportunity costs are important. 
The distribution of the latter will depend 
on how the intervention is funded. For 
example, if the funding comes from public 
health expenditure, health losses may be 
distributed unequally to those who are worse 
off, as they rely more on public services.13 
The study by Asaria et al.36 is the only one 
to present preferred strategies for when 
health opportunity costs are borne by the 
least healthy, the healthiest or are equally 
distributed. An important area for future 
research is to deliver improved estimates 
of the distribution of opportunity costs, 
and to determine a realistic distribution 
that plausibly reflects the impact of likely 
disinvestment decisions.
The use of health inequality measures is a 
constructive way forward where the aim is to 
compare different intervention options for 
their health inequality impact to allow ease of 
comparison and ranking of the interventions. 
Simple health inequality measures are easy 
to calculate and interpret, however they only 
take two SEP subgroups into account. The 
advantage of using complex health inequality 
Cost of Health  Equity in public health economic analyses
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measures is that they allow for a number of 
different interventions to be compared for 
their health inequality impact, taking into 
account each subgroup and its size. Whether 
one should consider measure of effect or 
the total impact depends on whether the 
size of the low SEP groups is considered a 
changeable aspect by policy-makers, (for 
example the income distribution), or whether 
to focus on the effect that is modifiable by 
public health policy.57 
A limitation of the use of health inequality 
measures is that they are subject to 
misinterpretation. The slope index of 
inequality and the relative index of inequality, 
for example, are complex to interpret and 
can easily lead to misunderstandings.57 The 
article by Asaria et al.36 would have benefited 
from more explicit interpretations of some 
of the inequality measures, including the 
implication of the size of the differences, 
to improve ease of understanding. Future 
studies should include a clear interpretation 
of each measure. The use of figures to 
compare results of health inequality measures 
of various policies could be useful. 
Given that all the studies considering equity 
for SEP across population groups were 
published in the past five years, application 
of this type of analysis is still in its infancy. In 
the health economics literature, for example, 
there is a well-developed literature on the 
pros and cons of including equity weights in 
economic appraisal, but only a limited and 
emerging literature on how to construct 
those equity weights. The estimate of 5% 
of economic evaluations in public health 
using SEP subgroup analysis is likely to be an 
underestimate, as the search only included 
the Econlit database. Econlit includes 
economics and business journals, however, 
an estimated 2.5 times as many health 
economics authors publish in PubMed listed 
journals.59 If this is the case, the percentage is 
likely to be closer to 1.5%. PubMed was not 
used for the estimation because it does not 
have a classification system by category.36,13
With regard to SEP specific mortality and 
morbidity in the modelling of health 
outcomes, it is important to note that the 
use of subgroup specific parameters, such as 
lower life expectancy and higher morbidity 
burden, may result in the evaluation of one 
subpopulation being less cost-effective than 
another. For example, lower SEP groups 
may have lower life expectancy and higher 
comorbidities resulting in lower health 
gains and higher ICERs. For this reason, an 
intervention that is cost-effective overall may 
not be cost-effective in lower SEP groups. 
Sensitivity analyses could include the use of 
general population life expectancy, quality of 
life estimates and treatment cost variations 
to compare the difference in results. Blakely 
et al.30 used this technique, although not for 
SEP, by applying non-Maori morbidity rates 
to Maoris and presented both sets of results. 
This was done because higher background 
mortality and morbidity rates for Maoris 
meant that in the baseline analysis a life 
saved for Maori was weighted less than a 
life saved for non-Maori. By comparing the 
two analyses, it is possible to check whether 
disadvantaged groups are being further 
disadvantaged. 
A recent article reviewed formal methods 
that consider equity in the context of CEA for 
health technology assessment (HTA), covering 
multiple concepts and values relating to 
equity.12 It identified one of the major 
obstacles hindering the use of formal equity 
methods in decision making, as the variety 
of concepts and values discussed under the 
notion of equity. Focusing on one key aspect 
of equity, such as SEP, allows for clarity. The 
methods of incorporating equity common 
to both HTA – an aspect of clinical medicine 
– and public health were equity weights and 
opportunity cost analysis.
One of the advantages of subgroup CEA 
is that it is an existing modelling method 
that health economists are familiar with 
performing, particularly in health technology 
assessment for heterogeneous characteristics, 
such as treatment effects. However, data 
requirements are more demanding and social 
distributions of key parameters are required. 
Trials are usually not designed or powered 
to detect subgroup effects as this requires 
additional resources, both for the collection 
and analysis of subgroup data. When health 
inequality impacts are a desired output of an 
intervention, the collection of SEP subgroup 
effectiveness data needs to be factored into 
the study protocol and budget.
Given the extra data requirements and 
costs involved, choices need to be made 
about when to conduct explicit health 
inequality analysis. When priority-setting 
decisions are being made around a set 
of potential interventions, as well as full 
economic evaluation studies to inform 
which interventions are both effective and 
cost-effective, the technical results of such 
evaluations need to be considered within a 
decision-making framework that explicitly 
considers health inequalities.60 Analysis 
of the health inequality impacts may also 
help with the restructuring of programs to 
encourage participation among lower SEP 
groups. The analysis can be done before they 
are implemented, but also retrospectively 
performed on existing programs. 
The methods of DCEA and ECEA are not 
widely used, however, future studies should 
consider using these techniques to provide 
policy makers with more useful information 
about the equity implications of policy 
options. When two or more interventions 
are being considered the inclusion of health 
inequality measures facilitates comparisons 
across key efficiency/equity objectives 
and should be included in future studies 
to enhance the information available to 
decision-makers. If financial impacts such 
as expenditure incurred or avoided are 
an important aspect of the policy, these 
should be included as part of the analysis. 
Equity weighting analysis can be used to 
quantify how much concern for equity is 
required when a trade-off between equity 
and cost-effectiveness is needed. It has been 
demonstrated that various weights can be 
applied, allowing the appropriate weight to 
be considered by decision makers along with 
stakeholders.11 Further research could gauge 
the usefulness of these methods for decision-
makers and stakeholders. It is important that 
results and inequality measures presented are 
easy to interpret. Feedback will be helpful to 
identify which health inequality measures are 
most useful in practice. 
Conclusions
As a reaction to growing policy concerns 
about health equity, there has been a move 
towards using CEA techniques to generate 
new information about the health equity 
implications of alternative policy options. The 
use of economic evaluation to investigate 
socioeconomic health inequality impacts 
of public health policies is relatively new 
and more work is required to allow ease of 
interpretation and comparison of measures 
being reported. The new techniques 
described have not been widely used to 
inform decision making, but it is hoped 
that these options are considered and used 
to provide policy makers with additional 
information about the health equity impacts 
of public health policies.
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